![Ying Ming Wang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ying Ming Wang
Direttore/Membro del Consiglio presso NOVOPROTEIN SCIENTIFIC INC.
Profilo
Ying Ming Wang is currently the Director at Novoprotein Scientific (Shanghai), Inc. since 2020.
Prior to this, Mr. Wang was the Director & Deputy General Manager at Suzhou Novoprotein Scientific Co., Ltd.
from 2009 to the present.
Mr. Wang graduated from Fudan University in 2014.
Posizioni attive di Ying Ming Wang
Società | Posizione | Inizio |
---|---|---|
NOVOPROTEIN SCIENTIFIC INC. | Direttore/Membro del Consiglio | 01/02/2019 |
Novoprotein Scientific (Shanghai), Inc.
![]() Novoprotein Scientific (Shanghai), Inc. Internet RetailRetail Trade Novoprotein Scientific (Shanghai), Inc. is a high-tech enterprise specializing in protein technology. Novoprotein Scientific (Shanghai is based in Shanghai, CN, with R&D and production bases in other locations, including Heze. The Chinese company's main focus is on biopharmaceuticals, in vitro diagnosis, vaccine drugs, and basic research on life sciences. The private company offers solutions such as targets and factor proteins, restructuring antibodies, enzymes, and reagents, and provide related technical services. The company was founded in 2009, and the CEO is Hua Xing Zhu. | Direttore/Membro del Consiglio | 12/08/2020 |
Formazione di Ying Ming Wang
Fudan University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
NOVOPROTEIN SCIENTIFIC INC. | Commercial Services |
Aziende private | 1 |
---|---|
Novoprotein Scientific (Shanghai), Inc.
![]() Novoprotein Scientific (Shanghai), Inc. Internet RetailRetail Trade Novoprotein Scientific (Shanghai), Inc. is a high-tech enterprise specializing in protein technology. Novoprotein Scientific (Shanghai is based in Shanghai, CN, with R&D and production bases in other locations, including Heze. The Chinese company's main focus is on biopharmaceuticals, in vitro diagnosis, vaccine drugs, and basic research on life sciences. The private company offers solutions such as targets and factor proteins, restructuring antibodies, enzymes, and reagents, and provide related technical services. The company was founded in 2009, and the CEO is Hua Xing Zhu. | Retail Trade |
- Borsa valori
- Insiders
- Ying Ming Wang